Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02845700 · ClinicalTrials.gov registry record · NA
Perceptual Retraining to Reduce Suicide Risk
A NA study, sponsored by Florida State University.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT02845700: Completed NA study, sponsored by Florida State University.
NCT02845700 is a NA study that has completed, run by Florida State University. The registered enrollment target is 13 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02845700, a NA study, has completed, sponsored by Florida State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
The study will use a prospective design consisting of three phases. The phases are: 1. the development of the perceptual retraining treatment (PRT), 2. the evaluation of the treatment's feasibility and acceptability, and 3. an assessment of its efficacy. During the third phase, a pilot study will be conducted in which participants will be randomly assigned to either PRT or a waitlist control group in order to assess efficacy. Diagnostic information and eligibility criteria will be assessed using the Structured Clinical Interview for Diagnostic and Statistical Manual (DSM) 4th ed. (SCID) and the Clinician Administered PTSD Scale for DSM-5 (CAPS-5).
Primary Outcome
A participant's ability to detect an array of threatening malodor in neutral dilution gradients will be tested at baseline and after the second and final intervention session (one week after baseline). Perceptual bias is calculated as the percentage of correct responses (i.e., yes or no to detecting the malodor) on an odor over 6 trials for each of the 8 odors, at 25% and 33% dilution (i.e., over 96 trials). Larger positive percentages indicate greater habituation to the malodor, and therefore a
Interventions
- BEHAVIORAL Perceptual Retraining Treatment
- BEHAVIORAL Sham Neutral training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2015-09 |
| Est. Completion | 2016-09 |
| Phase | NA |
What the finished NCT02845700 record still lists
NCT02845700 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Perceptual Retraining Treatment is the first listed.
NCT02845700 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02845700 about?
NCT02845700 is a clinical study titled "Perceptual Retraining to Reduce Suicide Risk". The study will use a prospective design consisting of three phases. The phases are: 1. the development of the perceptual retraining treatment (PRT), 2. the evaluation of the treatment's feasibility and acceptability, and 3. an assessment of its efficacy. During the third phase, a pilot study will ...
What is the current status of trial NCT02845700?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2015-09. Estimated completion is 2016-09.
What interventions are being tested in trial NCT02845700?
The interventions under investigation include: Perceptual Retraining Treatment (BEHAVIORAL), Sham Neutral training (BEHAVIORAL).
Who is sponsoring clinical trial NCT02845700?
This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02845700's enrollment target sits among peer trials
13 1911th of 2000 higher than 88 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia